- Meeting abstract
- Open Access
iNOS expression and levels of nitric oxide in a hepatocarcinogenesis model of p47-NADPH knockout mice
© Freiler et al; licensee BioMed Central Ltd. 2007
- Published: 14 November 2007
- Reactive Oxygen Species
- Nitric Oxide
- Wild Type Mouse
- Kupffer Cell
- Nitrogen Species
Nitrosamines occur in traces in food or may be generated endogenously. They are one chemical factor involved in hepatocarcinogenesis, a process mediated by genotoxic and cytotoxic events. Ethanol is a widely consumed hepatotoxic agent and has been shown to increase hepatocarcinogenesis in humans. Both compounds can activate Kupffer cells to produce cytotoxic reactive oxygen species (ROS) and growth promoting cytokines. Therefore, p47-NADPH oxidase knockout (phox-/-) mice were thought to be protected from hepatocarcinogenesis. We found that tumor formation in phox-/- took place, although to a lower extent than in wild type mice.
To examine whether reactive nitrogen species alternatively could be responsible for carcinogenesis in these livers. Experimental model: diethylnitrosamine (DEN) ; quantitative RT-PCR of iNOS mRNA; sum of nitric oxides by Griess reaction.
iNOS expression was increased in phox-/- as compared to wt mice. This is in agreement with a higher level of iNOS protein 24 hrs after DEN-treatment in phox-/- mice. However, total nitric oxide levels did not differ significantly between both strains. Correlation analysis of iNOS mRNA and NO levels on a per liver basis did not reveal significant associations.
We conclude that although iNOS appears to be induced in phox-/- mice the resulting nitric oxides may no longer be accessible for biochemical measurements at later times after treatment.
Grant support by Herzfelder'sche Familienstiftung is gratefully acknowledged.
- Freiler C, Brink A, Lutz WK, Kainzbauer E, Schulte-Hermann R, Parzefall W: Hepatocarcinogenesis by diethylnitrosamine (DEN) in NADPH knock-out mice and their wild-type counterparts. Pharmacology. 2006, 78: 155(T7)-Google Scholar
This article is published under license to BioMed Central Ltd.